Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Percutaneous Coronary Intervention: full-pipeline trial registry
3 of 13 indexed Percutaneous Coronary Intervention trials are currently recruiting.
Corpus placement: #1,315 of 28,707 conditions by registered trial count.
13 US clinical trials · 3 currently recruiting · #1,315 of 28,707 conditions by registered trial count
Percutaneous Coronary Intervention: 13 US clinical trials tracked, 3 recruiting.
Percutaneous Coronary Intervention is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Baystate Medical Center, running 2 of these trials.
Enrollment posture brief
Registry condition percutaneous-coronary-intervention
OPEN 3 | RECR 23% | LATE 3 | EARLY 2 | RANK #1315 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Endometrial Serous Adenocarcinoma (23% recruiting · 13 trials)
Percutaneous Coronary Intervention lists 3 open slots (23% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Percutaneous Coronary Intervention on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Percutaneous Coronary Intervention is recruiting below its size-band peers.
3 of 13 indexed trials (23.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Percutaneous Coronary Intervention research.
Baystate Medical Center accounts for 2 of 13 trials (15.4%). 12 distinct sponsors appear on at least one study for this condition label.
-
Typical Percutaneous Coronary Intervention enrolment sits around 447 participants.
Median target enrolment is 447 among the 13 trials that report a genuine target (sentinel values excluded). 2 of those (15.4%) plan for fewer than 100 participants.
-
Percutaneous Coronary Intervention splits between interventional and observational designs.
8 interventional and 5 observational studies make up this index (61.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
13 total, page 1 of 1
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Duke University
NCT06909565
Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
Baystate Medical Center
NCT05925634
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
VA Office of Research and Development
NCT04982419
Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
CathWorks
NCT05893498
Precision PCI Registry
University of Florida
NCT06143709
Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions
Minneapolis Heart Institute Foundation
NCT05187351
The xDAPT External Validation Study
Icahn School of Medicine at Mount Sinai
NCT06736626
Patient Centered Machine Learning Model for Bleeding and Ischemic Risk
Abbott Medical Devices
NCT06089304
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
Boehringer Ingelheim
NCT02164864
Enhancing Cardiac Rehabilitation Through Behavioral Nudges
Denver Health and Hospital Authority
NCT03834155
Management of Antiplatelet Regimen During Surgical Procedures
Baylor Research Institute
NCT03981835
Chewed Versus Integral Pill of Ticagrelor
Wake Forest University Health Sciences
NCT03708588
Exercise Prescription in Cardiac Rehabilitation
Baystate Medical Center
NCT03925493
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Percutaneous Coronary Intervention records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Percutaneous Coronary Intervention trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Percutaneous Coronary Intervention page
13 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Percutaneous Coronary Intervention trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Baystate Medical Center sponsors the most Percutaneous Coronary Intervention trials on record, review their full trial history before evaluating a specific study. See Baystate Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Percutaneous Coronary Intervention condition card totals 13 registered trials; most-linked intervention Percutaneous coronary intervention; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.